Saturday 17 October 2026 Export PBH’s income statement to Excel — free account

Prestige Consumer Healthcare Inc.

PBH Healthcare Drug Manufacturers Specialty & Generic

Prestige Consumer Healthcare Inc.’s revenue for fiscal 2026 (year ended March 2026) was $1.1 billion, down 4.31% from fiscal 2025. In the quarter to June 2026, revenue grew 6.48%, EPS fell 36.5%, free cash flow fell 14.2% and total debt rose 100.9%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.

49.92 0.72 +1.46%

Follow PBH

Alert me

Market cap: $2.3B
P/E: 13.9×
Fwd P/E: 10.3×
Dividend yield: —
F-score: 5/9
Altman Z: 2.48
Beneish M: −2.53
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	15.37	16.19	15.04	13.17
P/S ratio Full definition →		2.75	2.68	2.64	2.03
P/FCF ratio Full definition →		11.98	11.05	11.65	9.53
P/Operating CF Full definition →		53.22	37.73	67.04	31.69
P/B ratio Full definition →		1.68	1.61	1.52	1.17
Price to Tangible BV Full definition →		0.00	0.00	0.00	0.00
EV/Sales Full definition →		3.57	3.58	3.52	3.79
EV/EBITDA Full definition →		10.92	11.16	11.18	12.92
EV/Operating CF Full definition →		15.04	14.29	14.87	16.80
EV/FCF Full definition →		15.51	14.80	15.54	17.80
Quick Ratio Full definition →		2.36	1.81	2.12	1.80
Current Ratio Full definition →		3.70	3.11	3.57	3.23
Net Debt/EBITDA Full definition →		10.18	10.93	11.25	31.52
Debt/Assets Full definition →		29.41%	30.11%	28.96%	44.54%
Debt/Equity Full definition →		0.55	0.58	0.54	1.06
Asset Turnover Full definition →		0.33	0.32	0.32	0.28
Operating CF/Net income Full definition →		1.36	1.68	0.79	2.43
Capex/Depreciation Full definition →		(0.26)	(0.38)	(0.59)	(0.40)
Interest Coverage Full definition →		7.94	7.73	6.61	3.77
Research and Development Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →		24.35%	24.60%	23.21%	29.34%
Intangible Assets out of Total Assets Full definition →		0.82	0.82	0.82	0.85
Share Based Compensation of Revenue Full definition →		0.64%	0.97%	0.94%	1.50%
Graham Net Nets Full definition →		(0.37)	(0.42)	(0.41)	(0.96)
Graham Number Full definition →		58.31	57.23	58.76	57.11
Earnings Yield Full definition →		6.51%	6.18%	6.65%	7.59%
Free Cash Flow Yield Full definition →		8.35%	9.05%	8.58%	10.49%
Revenue per Share Full definition →		5.59	5.92	5.81	5.60
Operating CF per Share Full definition →		1.17	1.64	0.88	1.49
Capex per Share Full definition →		(0.04)	(0.06)	(0.11)	(0.08)
Free Cash Flow per Share Full definition →		1.13	1.57	0.78	1.41
Cash per Share Full definition →		2.43	1.30	1.32	1.88
Shareholders Equity per Share Full definition →		37.23	38.21	38.95	40.38
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		37.23	38.21	38.95	40.38
Free Cash Flow Full definition →		55.38	75.26	37.63	67.09
Working Capital Full definition →		362.81	293.87	310.56	343.01
Capital Expenditures Full definition →		(2.10)	(3.03)	(5.21)	(3.70)
Net Current Asset Value Full definition →		(1,119.90)	(1,231.86)	(1,175.31)	(2,155.04)
EV/EBIT Full definition →		11.94	12.26	12.38	14.44
Capex to Sales Full definition →		0.01	0.01	0.02	0.01
Price to Operating Income Full definition →		9.22	9.16	9.28	7.73
Other line items
Average Receivables Full definition →		181.27	178.87	193.11	177.88
Average Payables Full definition →		36.55	31.23	20.86	29.53
Average Inventory Full definition →		157.61	157.56	153.42	171.67
Average Assets Full definition →		3,379.58	3,412.12	3,448.27	4,000.10
Average Common Equity Full definition →		1,778.37	1,808.94	1,861.21	1,886.10

Show all line items

Columns are period end dates

Stockrow Weekly